Key result
The CAVRED platform achieved rapid identification of SARS-CoV-2 variants in 40 simulated throat swab samples with 95.0% accuracy within 20 minutes.
Why the study?
The COVID-19 epidemic and rapid mutation of SARS-CoV-2 established new requirements for virus detection and identification techniques for mass pathogen screening.
Answers are grounded in this paper and cite their sources.
The CAVRED platform offers a rapid, amplification-free, and highly accurate method for detecting SARS-CoV-2 variants at single-nucleotide resolution.
Mass pathogen screening is critical to preventing the outbreaks and spread of infectious diseases. The large‐scale epidemic of COVID‐19 and the rapid mutation of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus have put forward new requirements for virus detection and identification techniques. Here, we report a CRISPR‐based Amplification‐free Viral RNA Electrical Detection platform (CAVRED) for the rapid detection and identification of SARS‐CoV‐2 variants. A series of CRISPR RNA assays were designed to amplify the CRISPR‐Cas system‘s ability to discriminate between mutant and wild RNA genomes with a single‐nucleotide difference. The identified viral RNA information was converted into readable electrical signals through field‐effect transistor biosensors for the achievement of highly sensitive detection of single‐base mutations. CAVRED can detect the SARS‐CoV‐2 virus genome as low as 1 cp μL −1 within 20 mins without amplification, and this value is comparable to the detection limit of real‐time quantitative polymerase chain reaction. Based on the excellent RNA mutation detection ability, an 8‐in‐1 CAVRED array was constructed and realized the rapid identification of 40 simulated throat swab samples of SARS‐CoV‐2 variants with a 95.0 % accuracy. The advantages of accuracy, sensitivity, and fast speed of CAVRED promise its application in rapid and large‐scale epidemic screening.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2023) studied SARS-CoV-2 (n=40). CAVRED (CRISPR-based Amplification-free Viral RNA Electrical Detection) was evaluated on Accuracy of rapid identification of SARS-CoV-2 variants. The CAVRED platform achieved rapid identification of SARS-CoV-2 variants in 40 simulated throat swab samples with 95.0% accuracy within 20 minutes.
Synapse has enriched 10 related papers. Consider them for comparative context: